drugset / Trial / NCT01634789
A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study is to evaluate 3 test formulations relative to a reference formulation.
Timeline
- Start
- 2012-08
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bazedoxifene | Other / unclassified | 20 mg | Oral |
| Subject | conjugated estrogens | Other / unclassified | 0.625 mg | Oral |
Indications
No indication recorded.